|
|
 Feature storyRegistration of Normosang in Russia The 14/11/2011 at 17:53:26 Orphan Europe is pleased to announce that Normosang (human hemin) has received market approval, in Russia for the treatment of acute attacks of hepatic porphyria (acute intermittent porphyria, hereditary coproporphyria and variegate porphyria. Download here Orphan Europe is pleased to announce that Normosang (human hemin) has received market approval, in Russia for the treatment of acute attacks of hepatic porphyria (acute intermittent porphyria, hereditary coproporphyria and variegate porphyria. Download here Back |
| Design by Cyim 2007